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Macrophage  migration  inhibitory  factor  (MIF)  was
initially described as a soluble factor identified during the
delayed  hypersensitivity  reaction  [1].  The  presence  of
macrophages  at  the  inflamed  site  is  the  origin  of  the
nomenclature of this interesting cytokine [1,2]. Therefore, the
role  of  MIF  was  initially  recognized  as  a  unique  pro-
inflammatory cytokine and was considered essential for T-cell
activation.  However,  the  results  of  recent  studies  have
revealed that the role of MIF is not limited to inflammation;
rather, it is also profoundly involved in the regulation of
cellular growth [2], wound healing [3], tissue development,
and  even  tumor  formation  under  a  variety  of  pathologic
conditions [4]. Previous investigations have revealed MIF
expression in a variety of tissues, including the brain, ear,
lung, breast, liver, testis, vascular endothelial cell, vascular
smooth muscle cells, skin, kidney, endocrine glands (pituitary
gland, adrenal cortex, and pancreas), and eye (lens, cornea,
iris, ciliary body, lacrimal gland, and retina) [5,6].
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The vital function of MIF in the wound healing process
was studied previously. Elevated local levels of MIF were
associated with elevated inflammatory response and marked
delays in wound healing in human and mouse skin wound
models  [3].  On  the  other  hand,  other  studies  have
demonstrated  that  MIF  promotes  fibroblast  migration  and
accelerates skin wound healing [7,8]. A close relationship
between MIF and vascular endothelial growth factor (VEGF)
expression has recently been reported [9,10].
The wound healing response after tissue injury is critical
to the individuals’ survival. In nonocular tissues, the cicatrical
change accompanying new vessels and strong fibrosis may be
beneficial, providing superior structural stability. However,
considering  the  transparent  nature  of  the  cornea  and  the
smooth and wet conjunctival surface of the normal ocular
environment, it is clearly necessary to minimize fibrosis and
new vessels in the process of wound healing following ocular
surface trauma. One good example of this is chemical burns
to the ocular surface, especially those induced by alkaline
agents. This condition characterized by severe inflammation
disrupts or destroys the normal homeostasis of corneal and
conjunctival epithelial cells [11]. The induced deficiency of
the limbal stem cell population of corneal epithelium results
in clinically significant opacity, new vessel formation, and
persistent epithelial corneal defects [11-13]. The cicatrical
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Purpose: To evaluate the role of macrophage migration inhibitory factor (MIF) in the wound healing process following
severe chemical burns to the ocular surface.
Methods: Chemical burning of the ocular surface was induced in mice (C57BL/6) via the application of 0.1 M NaOH.
Macrophage migration inhibitory factor (MIF), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) mRNA
expression in the ocular surface and lacrimal gland was evaluated via real-time reverse transcription PCR on days 2, 7,
and 30 after induction of the chemical burn. The expression of MIF protein in the ocular surface and lacrimal gland was
evaluated via western blot analysis. Immunohistochemical staining was conducted to detect MIF and vasculoendothelial
growth factor in the cornea during the wound healing process. The angiogenic role of MIF was further evaluated using
an 8–0 polyglactin suture technique to induce corneal neovascularization.
Results: MIF, TNF-α, and IL-1β mRNA expression were elevated significantly in the ocular surface up to day 30 after
chemical burn induction. TNF-α alone was elevated in the lacrimal gland. MIF protein elevation was confirmed via western
blot analysis, and the spatial similarity of MIF and VEGF expression in the cornea was noted during the wound healing
process. 8–0 polyglactin sutures soaked in MIF induced significantly higher numbers of new vessels on the mouse cornea
after 7 days (p=0.003, Mann–Whitney test).
Conclusions: These findings indicate that MIF performs a crucial role in wound healing on the ocular surface after the
induction of chemical burns.change in the conjunctiva results in tear film abnormalities
and dry eye [11-13].
During  the  wound  healing  process,  many  cytokines
secreted either from ocular resident cells or from recruited
inflammatory cells are involved in the pathogenesis. Tumor
necrosis  factor-  α  (TNF-  α),  interleukin-1  (IL-1),
interleukin-6,  interleukin-10,  and  VEGF  are  some  of  the
cytokines that were previously studied extensively in ocular
chemical burn experiments [14-18]. And MIF is also a strong
candidate molecule. Because MIF is also closely related to
both fibrosis and neovascularization [7-10], the role of MIF
in  ocular  wound  healing  was  previously  studied.  MIF
expression in the cornea was upregulated in animal models
after mechanical corneal damage or infection [19,20]. MIF
knockout mice exhibited reduced corneal neovascularization
relative to the wild-type mice following corneal nylon suture
or alkali burn [19]. These studies implied that MIF might
perform an important function in ocular cicatrical changes
occurring after trauma.
Recently  our  group  reported  a  high  level  of  MIF
expression in the normal murine lacrimal gland and a dynamic
change  of  MIF  expression  in  an  experimentally  induced
murine  dry  eye  model  [6,21,22].  In  previous  studies  we
induced local change in the lacrimal gland via a focal injection
of botulinum toxin type B into the main lacrimal gland. This
induced experimental dry eye and was associated with the
sustained elevation of MIF expression within the lacrimal
glands. However, no significant changes in MIF in the ocular
surface were detected [21,22]. In a clinical setting, dry eye and
chemical burn differ profoundly in pathogenesis. Chemical
burns destroy the ocular surface far beyond the extent of dry
eye. Although no significant role for MIF on the ocular surface
was detected in our dry eye model, the role of MIF in chemical
burns could differ profoundly.
In the present study we induced severe inflammation on
the ocular surface via the induction of chemical burns (NaOH)
in mice. We explored the expression of MIF, TNF-α, and IL-1
both in the ocular surface and lacrimal gland via real-time
reverse transcription PCR (real-time RT–PCR) and western
blot analysis. Vascularization of the cornea is the ultimate
result of severe ocular surface inflammation, and VEGF is
considered a major regulator of new corneal vessels. Thus, we
evaluated the possible relationship existing between VEGF
and MIF expression in corneal cells during the process of
wound  healing  after  the  induction  of  chemical  burns  via
immunohistochemistry.  Furthermore,  we  evaluated  the
effects  of  exogenous  MIF  on  induced  corneal
neovascularization using a suture-induced model.
METHODS
Animals:  Ninety-three  male,  7-week-old  C57BL/6  mice
(Dooyeol Biotech, Seoul, Korea) were used in accordance
with  the  Association  for  Research  in  Vision  and
Ophthalmology  Statement  for  the  Use  of  Animals  in
Ophthalmic and Vision Research. The experimental protocol
was  approved  by  the  Institutional  Animal  Care  and  Use
Committee of Dongguk University.
Ten mice were used as a control group. The eyes and
lacrimal glands were harvested after euthanizing the animals
(overdose  sedation  using  xylazine  and  ketamine  before
cervical dislocation). Ten samples from the right eyes were
used  for  RNA  extraction  and  real-time  RT–PCR,  and  10
samples from the left eyes were fixed in formalin and used for
histology and immunohistochemistry. Another 75 mice were
divided into groups 1, 2, and 3 (n=25, each group). After
induction of chemical burns in the right eyes (0.1 M NaOH,
20  µl  application  on  the  ocular  surface  for  30  s  with  no
washing), group 1 mice were sacrificed 48 h after chemical
burn induction, group 2 mice were sacrificed 7 days after
chemical burn induction, and group 3 mice were sacrificed 30
days after chemical burn induction. The eyes and lacrimal
glands were harvested from both the right and left sides. The
tissues from the left side were used as controls. Fifteen right
eyes of each group were used for RNA extraction and real-
time RT–PCR, five right eyes of each group were used for
histology and immunohistochemistry, and five right eyes of
each group were used for protein extraction and western blot
analysis.  Another  eight  mice  received  8–0  polyglactin
(Catalog no:W9560; Coated Vicryl; Ethicon, Cornelia, GA)
corneal sutures to induce the formation of new corneal vessels.
Quantitative  real-time  reverse  transcription  PCR:
Enucleation was performed, and the main lacrimal gland was
harvested en bloc. The ocular surface tissues containing the
whole cornea, conjunctiva, and the anterior half of the sclera
were  obtained.  Total  RNA  was  isolated  from  the  ocular
surface  and  lacrimal  gland  using  an  RNeasy  kit  (Qiagen,
Valencia,  CA)  in  accordance  with  the  manufacturer’s
instructions. The RNA concentrations were determined via
ultraviolet  spectrophotometry.  RNA  samples  were  treated
with DNase I (Catalog No. 18047–019; Invitrogen, Carlsbad,
CA)  to  preclude  genomic  DNA  contamination.  The  first-
TABLE 1. PRIMER SEQUENCES FOR PCR.
Gene GeneBank acession Left primer Right primer PCR product (bp)
IL-1β NM_008361 GCCCATCCTCTGTGACTCAT AGGCCACAGGTATTTTGTCG 229
TNF- α NM_013693 GAACTGGCAGAAGAGGCACT AGGGTCTGGGCCATAGAACT 201
MIF NM_010798 GTGCCAGAGGGGTTTCTGT AGGCCACACAGCTTACT 205
Cyclophilin A XR_004644 CAGACGCCACTGTCGCTTT TGTCTTTGGAACTTTGTCGCAA 132
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oligo  d'-T  primer  using  a  commercially  available  kit
(SuperScriptTM  Ш  Reverse  Transcriptase;  Invitrogen,
Carlsbad, CA). Aliquots of samples of cDNA were stored at
–80 °C until use. Real-time quantitative PCR was conducted
and analyzed with a Roche Light-Cycler. (LightCycler 1536;
Roche, Basel, Switzerland) Reactions in a 20 µl volume were
conducted using SYBR Green reaction mix (Qiagen) with
0.5 mM of primer. Cyclophilin A was used as normalization
standard. Assays were conducted in triplicate. The measured
value of the right organ was compared to the measured value
of the left organ in each mouse. The value of the right organ
divided  by  the  value  of  the  left  organ  was  employed  for
analysis. The sequences of the PCR primer pairs are listed in
Table 1.
Histology and immunohistochemistry: Harvested tissues were
formalin  fixed  and  paraffin  blocks  were  prepared.  Four
micron-thick  sections  were  obtained  from  formalin-fixed,
paraffin-embedded tissues, transferred onto adhesive slides,
and dried at 60 °C for 40 min. The immunohistochemical
procedures  were  then  conducted  using  a  BenchMark  XT
automatic  immunohistochemical  staining  device  (Ventana
Medical  System,  Tucson,  AZ).  After  dewaxing  and
rehydrating, antigen retrieval was performed. The slides were
then incubated for 30 min at 42 °C with MIF polyclonal
antibodies (1:2,000, Catalog no: 36–7401; Zymed, Carlsbad,
CA) or VEGF monoclonal antibodies (1:200, Catalog no:
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Figure 1. Histology of the mouse eye after induction of chemical burns by 0.1 M NaOH. Chemical burns induced with 0.1 M NaOH induced
severe inflammatory changes on the ocular surface. Representative figures are shown. A: Control eye, no chemical burn induced. B: Two days
after chemical burn. Severe infiltration by inflammatory cells and total loss of the epithelial layer are observed. C: Seven days after chemical
burn. Corneal inflammation is reduced compared to day 2; corneal edema persists; epithelial layer has regenerated. D: Thirty days after
chemical burn. Inflammation has almost completely subsided; however, marked increases in corneal stromal thickness and cellularity persist.ab1316; Abcam, Cambridge, MA). The primary antibodies
were detected using an iVIEW DAB detection kit (Ventana
Medical System).
Western blot analysis: For western blot analysis, the ocular
surface tissues stored at –80 °C were quickly homogenized
with a tissue crusher while frozen, and the tissue powder was
placed into boiling lysis buffer (1% sodium dodecyl sulface,
1.0 mM sodium ortho-vanadate, 10 mM Tris [pH 7.4]), placed
into a microwave oven for 15 s, and centrifuged for 5 min at
11,400× g at 15 °C. The samples were then separated via SDS–
PAGE under denaturing conditions and electroblotted onto a
polyvinylidine difluoride membrane (BioRad, Hercules, CA).
After being blocked using 5% nonfat dry milk in Tris-buffered
saline containing 10 mM Tris (pH 7.6), 150 mM NaCl, and
0.1% Tween-20, the membranes were incubated with rabbit
antimouse MIF polyclonal antibodies (Catalog no: 36–7401;
Zymed) and diluted to 1:200 in blocking solution overnight at
4  °C.  The  membranes  were  further  incubated  with  an
antirabbit horseradish peroxidase-conjugated antibody (Santa
Cruz Biotechnology, Santa Cruz, CA). They were then treated
with  an  enhanced  chemiluminescence  solution  (ECL  kit;
Pierce, Rockford, IL), and the signals were captured on an
image reader (Las-3000; Fuji Photo Film, Tokyo, Japan). To
monitor the amount  of protein loaded into each  lane, the
membranes were treated with a stripping buffer and reprobed
with a monoclonal antibody against β-actin (Sigma-Aldrich,
St  Louis,  MO).  The  protein  bands  were  analyzed  via
densitometry. The ratio between the control and sample was
calculated asfollows:
Ratio =
right tissue (density of MIF divided by density of β-actin
left tissue (density of MIF divided by density of β-actin
Mouse  corneal  neovascularization  assay:  Mouse  corneal
neovascularization was induced using a 3-mm bite length of
8–0 polyglactin suture near the limbus. Eight mice were used.
The  right  eyes  received  sutures  incubated  in  recombinant
mouse MIF (10 μg/ml, Catalog No: 1978-MF; R&D Systems,
Minneapolis, MN) for 48 h. The left eyes received sutures
incubated in PBS (Catalog No: 14190–250, no magnesium,
no calcium, no phenol red; GIBCO, Grand island, NY) for 48
h. After 7 days, both the cornea and conjunctiva were digitally
photographed  (Nikon  D3000;  Nikon,  Tokyo,  Japan)  and
angiogenesis scoring was conducted. Angiogenic activity was
scored as the number of newly developed vessels crossing the
Figure 2. Macrophage migration inhibitory factor immunohistochemistry in normal and chemical burn applied to the mouse eye. In normal
control eyes, MIF was expressed in the corneal epithelium, corneal endothelium, lens epithelium, and ciliary body epithelium (A, B). However,
it was difficult to find any significant MIF staining in the corneal stroma. C: Negative control; secondary antibody staining without primary
antibody application. D: MIF expression was detectable in corneal stroma at day 2 after chemical burn induction. However, the infiltrating
inflammatory cells were largely negative for MIF expression (inserted figure in panel D is the magnification of area indicated by the clear
arrow). E, F: MIF staining on days 7 and 30 after chemical burn. MIF expression in the corneal stroma was increased but cellular infiltration
was reduced compared to day 2.
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angiogenic activity was compared between the right and left
eyes.
Statistical analysis: SPSS version 12.0 for Windows (SPSS
Inc. Chicago, IL) was used for statistical analysis. Mann–
Whitney  tests  were  conducted  for  analysis  of  difference
between the two groups. The Kruskal–Wallis test and least
significant  difference  test  (using  ranks  for  multiple
comparisons)  were  used  for  analyses  of  the  difference
between three or more groups. A p value of less than 0.05 was
prospectively  assigned  as  the  threshold  for  statistical
significance.
RESULTS
Histology of chemical burn of murine ocular surface: Eyes
evidenced  severe  inflammation  after  the  induction  of
chemical burns by NaOH. The corneas were grossly swollen
and  hazy.  Heavy  infiltration  by  inflammatory  cells  was
observed at full thickness in the cornea, and was particularly
severe in the superficial layer. Occasionally, the total absence
of epithelial layers and a marked reduction in endothelial cells
were  noted.  This  acute  change  recovered  partially  over  4
weeks,  although  the  increased  corneal  thickness  and
cellularity persisted (Figure 1).
Macrophage  migration  inhibitory  factor  and  vascular
endothelial growth factor immunohistochemistry: MIF was
expressed in the corneal epithelium, corneal endothelium,
conjunctival epithelium, lens epithelium, and ciliary body
epithelium. In the epithelial layer of the cornea, MIF staining
was positive with more prominent expression in the basal
cells. The corneal stromal layer was negative for MIF staining
(Figure 2).
After chemical burn induction, MIF staining could be
readily observed in the corneal stromal layer in all samples.
However,  the  infiltrating  inflammatory  cells  were  mostly
negative for MIF. Interestingly, MIF was expressed in cells
around  the  microvessels  and  evidenced  a  high  degree  of
spatial similarity with VEGF expression (Figure 3). Whereas
the corneal changes were prominent, the conjunctival changes
were difficult to discriminate, owing to scanty tissue in the
mice.
Real-time  RT–PCR  for  macrophage  migration  inhibitory
factor,  interleukin-1β  and  tumor  necrosis  factor-α:  The
mRNA expression levels of MIF, IL-1β, and TNF-α were
evaluated via real-time RT–PCR. In the ocular surface, MIF,
IL-1β, and TNF-α expression were significantly elevated after
chemical burn induction on days 2, 7, and 30. MIF and TNF-
α  expression  increased  steadily  for  4  weeks  after  injury.
However, the elevation of IL-1β was dramatic at day 2 and
Figure 3. Macrophage migration inhibitory factor and vascular endothelial growth factor immunohistochemistry after chemical burn of ocular
surface. Thirty days after induction of chemical burns on the ocular surface, the murine corneas were stained with antibodies against MIF
(A) and VEGF (B). The inflammation almost completely subsided, and irregularly distributed corneal stromal fibers were noted, with a few
microvessels (arrow). Both cytokines were readily observable in the corneal stroma and epithelium. Their expression revealed high spatial
similarity as demonstrated in the inserted magnified images. In the epithelial cell layer, both MIF and VEGF were heavily expressed in basal
cells as compared to cells in the superficial layers. Both VEGF and MIF were positively stained in cells around microvascular structures
(asterisk). The inserted magnified image represents the areas indicated by the arrow and asterisk.
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maintained at elevated levels relative to the controls (Figure
4).  MIF  and  IL-1β  in  the  lacrimal  gland  evidenced  no
significant changes after chemical injury to the ocular surface.
However,  the  expression  level  of  TNF-α  was  increased
significantly on days 2 and 7 after injury. This change in TNF-
α normalized on day 30 after injury (Figure 4).
Western blot analysis: Western blot analysis of MIF in the
ocular surface revealed significant elevation on days 2, 7, and
30 (Figure 5). However, western blot analysis of MIF in the
lacrimal gland revealed no significant elevation after chemical
burn induction (Figure 5).
Induction  of  mouse  corneal  neovascularization  with
macrophage  migration  inhibitory  factor:  Sutures  induced
significant corneal neo-vessels, using both PBS-incubated or
MIF-incubated  polyglactin.  However,  angiogenic  activity
(vessel score) was significantly higher in the MIF-incubated
polyglactin (p=0.003, Mann–Whitney test) relative to the PBS
controls on day 7 after suture placement (Figure 6).
DISCUSSION
Our data reveal that MIF plays a prominent role in the alkali-
burned murine eye. On the ocular surface after chemical burn
induction, MIF protein was expressed at elevated levels (real-
time RT–PCR and western blot) and was abundantly noted in
the  corneal  stromal  cells,  which  normally  lack  MIF
expression. The infiltrating inflammatory cells were negative
for  MIF  expression.  Additionally,  MIF  expression  was
prominent in the cells surrounding microvessels and was co-
localized with VEGF expression. Real-time PCR showed that
the  kinetics  of  MIF  expression  were  similar  to  other
inflammatory cytokines, including TNF-α and IL-1β. MIF
mRNA was elevated in the ocular surface for 4 weeks after
injury. In the lacrimal glands, MIF protein and mRNA were
not elevated at any time. Because VEGF is one of the best
known cytokines involved in the induction of new vessels
under pathologic conditions, the co-existence of MIF and
VEGF  in  similar  locations  indicates  that  MIF  plays  an
important  role  in  corneal  neovascularization.  Here,  we
Figure  4.  Real-time  RT–PCR  for
macrophage migration inhibitory factor,
interleukin-1β,  and  tumor  necrosis
factor-α  in  the  ocular  surface  and
lacrimal gland after chemical burn (at
days  2,  7,  and  30  after  injury).  A-C:
Ocular  surface;  panels  D-F:  lacrimal
gland.  A:  MIF  expression.  MIF  is
elevated  in  the  ocular  surface  after
chemical burn induction on days 2, 7,
and 30 relative to the controls. P values:
day  0  versus  day  2  (p<0.001),  day  0
versus day 7 (p=0.003), day 0 versus day
30  (p=<0.001),  otherwise  not
significant. B: The expression of IL-1β.
IL-1β  evidenced  dramatic  changes  in
the ocular surface after chemical burn
induction. P values: day 0 versus day 2
(p<0.001),  day  0  versus  day  2
(p=0.001),  day  0  versus  day  3
(p=0.002), otherwise not significant. C:
TNF-α expression. TNF-α is elevated in
the ocular surface after chemical burn. P
values: day 0 versus day 2 (p=0.009),
day  0  versus  day  7  (p=0.032),  day  0
versus day 30 (p=0.049), otherwise not
significant. D: The expression of MIF.
E:  The  expression  of  IL-1β.  F:  The
expression  of  TNF-α.  Both  MIF  and
IL-1β evidenced no significant changes
in  the  lacrimal  gland  after  chemical
burn. However, TNF-α is elevated in the
lacrimal gland after chemical burn. P
values: day 0 versus day 2 (p=0.001),
day 2 versus day 7 (p=0.020), otherwise
not significant. Error bars show mean
±1.0 standard error; bars show means.
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demonstrated that the exogenous application of MIF together
with sutures significantly enhances new vessel formation in
the mouse cornea.
MIF performs many interesting biologic functions. MIF
has been described previously as important in the immune
response [1,2,5], angiogenic [23,24], both a promoter and an
inhibitor of wound healing [3,7,8], a promoter of fibrosis [8,
25-28], an upregulator of matrix metalloproteinases in the
promotion  of  vessel  growth  [29-31],  and  a  promoter  of
angiogenic factors, such as VEGF and IL-8 [32,33].
In  our  study  we  determined  that  MIF  is  abundantly
expressed in corneal stromal cells, and the distribution of MIF
in the corneal stroma closely matches that of VEGF. This
finding is consistent with previous reports revealing that MIF
promotes VEGF and together with the destruction of stroma
via the upregulation of metalloproteinases, MIF and VEGF
may  enhance  the  formation  and  growth  of  new  vessels.
Additionally, we determined that MIF expression was absent
in infiltrating corneal inflammatory cells; this result differs
from the previously reported finding that MIF was found
principally in infiltrating cells in the corneal stroma after
ocular surface injury [19]. The finding that MIF expression in
the corneal stroma increased while inflammation subsided
during the wound healing process also reflects that increased
MIF originated principally from corneal stromal cells.
Interestingly,  the  cells  involved  in  microvessel
construction  were  positive  for  both  MIF  and  VEGF.
Furthermore, the kinetics of MIF expression were correlated
with inflammatory cytokines, such as TNF-α and IL-1. This
suggests that MIF interacts not only with VEGF but also with
other inflammatory cytokines in our ocular chemical burn
model. MIF was previously determined to induce TNF-α and
IL-1 β expression from the peripheral blood mononuclear
cells [34]. Additionally, TNF-α was reported to induce the
secretion of MIF from dendritic cells and ovarian cancer cells
[35,36]. Recently, anti-TNF therapy resulted in reduced serum
MIF  levels  in  patients  with  rheumatoid  arthritis  [37].
Therefore, these cytokines may cross-regulate one another in
the pathologic cornea and participate in the wound healing
response.
Whether  the  elevation  of  MIF  on  the  ocular  surface
promotes  or  delays  wound  healing  remains  to  be  clearly
elucidated. In a previous report it was determined that MIF
was  advantageous  for  corneal  recovery  after  ultraviolet-
induced  photokeratitis  in  mice  [38].  However,  when
considering both the pro-inflammatory and angiogenic effects
of MIF, further studies will be necessary to clarify the role of
MIF in ocular surface wound healing.
It is interesting to note that MIF and IL-1β in the lacrimal
gland evidenced no significant changes during the wound
healing process after chemical burn induction, whereas TNF-
α in the lacrimal gland was significantly elevated in the same
Figure 5. Western blot for macrophage
migration inhibitory factor in the ocular
surface  and  lacrimal  gland  after
chemical burn (at days 2, 7, and 30 after
injury). A: western blot for MIF in the
ocular surface. S is the study eye and C
is  the  control  eye.  The  number
designates  the  serial  number  of  each
mouse. The arrows indicate prominent
elevations  of  MIF  in  the  study  eyes
relative to the controls. B: Means and
standard  errors  of  density  calculated
from western blotting. MIF is elevated
in the ocular surface on days 2, 7, and 30
after chemical burn. P values: control
versus day 2 (p=0.004), control versus
day 7 (p=0.028), control versus day 30
(p=0.010), otherwise not significant. C:
western  blot  for  MIF  in  the  lacrimal
gland. S is the study eye and C is the
control  eye.  Numbers  designate  the
serial number of each mouse. D: Means
and standard errors of density calculated
from western blot. MIF evidenced no
significant  differences  in  the  lacrimal
gland  after  chemical  burn.  Error  bars
show  mean±1.0  standard  error;  bars
show means.
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induced  murine  dry  eye  model,  TNF-α  and  IL-1β  were
increased  on  both  the  ocular  surface  and  lacrimal  gland,
whereas MIF was increased only in the lacrimal gland [21,
22].  Considering  the  differences  in  pathogenesis  between
chemical  burn  and  dry  eye,  the  discrepancy  in  cytokine
expression  in  the  two  different  disease  models  is  quite
understandable.
In the clinical setting the wound healing response after
severe ocular surface chemical burns is usually accompanied
by corneal haziness, fibrosis, and neovascularization [11]. A
variety of therapeutic strategies, including limbal stem cell
transplantation,  amniotic  membrane  application,  and
autologous serum eye drops, have been used in attempts to re-
establish  the  destroyed  ocular  surface  following  severe
chemical  burns  [11-13,39].  However,  if  the  inflammation
caused  by  a  chemical  burn  can  be  minimized  via  early
intervention with an effective therapeutic agent, the overall
prognosis  of  the  disease  would  be  likely  to  improve.
Therefore,  investigations  into  appropriate  candidate
molecules  are  very  important.  The  targeting  of  matrix
metalloproteinase and VEGF have already yielded significant
results [40-42]. Considering the nature of ocular chemical
burns,  molecules  involved  in  both  inflammation  and
angiogenesis, such as MIF, should be included as targets for
future therapeutic interventions.
In conclusion, the data collected herein demonstrate the
significance of MIF in the wound healing process following
injuries to the ocular surface. Modulating MIF on the ocular
surface after a chemical burn may offer new opportunities to
improve visual outcomes.
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